S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
TSE:BHC

Bausch Health Companies - BHC Stock Forecast, Price & News

C$10.52
+0.13 (+1.25%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
C$10.40
C$10.80
50-Day Range
C$8.27
C$11.33
52-Week Range
C$5.10
C$33.39
Volume
614,649 shs
Average Volume
692,042 shs
Market Capitalization
C$3.81 billion
P/E Ratio
10.31
Dividend Yield
N/A
Price Target
C$29.00
BHC stock logo

About Bausch Health Companies (TSE:BHC) Stock

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

BHC Stock News Headlines

BHC Bausch Health Companies Inc.
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Canadian Stocks Firmly Down In Negative Territory At Noon
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Bausch (BHC) Q3 Earnings & Sales Miss, Guidance Lowered
Bausch + Lomb beats earnings expectations in Q3
See More Headlines
Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

BHC Company Calendar

Today
2/02/2023
Next Earnings (Confirmed)
2/23/2023

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
19,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$29.00
High Stock Price Forecast
C$32.00
Low Stock Price Forecast
C$26.00
Forecasted Upside/Downside
+175.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$8.13 billion
Cash Flow
C$1.36 per share
Book Value
C($1.45) per share

Miscellaneous

Free Float
N/A
Market Cap
C$3.81 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Thomas J. Appio (Age 60)
    CEO & Director
    Comp: $2.9M
  • Mr. Thomas G. Vadaketh (Age 59)
    Exec. VP & CFO
  • Mr. Mirza Dautbegovic
    Sr. VP & COO
  • Mr. John S. Barresi (Age 49)
    Sr. VP, Controller & Chief Accounting Officer
  • Dr. Robert F. Butz
    VP of Medical & Scientific Affairs
  • Mr. Arthur J. Shannon
    Sr. VP and Head of Investor Relations & Global Communications
  • Ms. Seana Carson (Age 50)
    Exec. VP & Gen. Counsel
  • Ms. Kathleen Fitzpatrick
    Sr. VP & Chief HR Officer
  • Dr. Tage Ramakrishna M.D. (Age 48)
    Chief Medical Officer and Pres of R&D
  • Mr. Jeff Hartness
    Sr. VP of Market Access, Commercial Operations & Gov. Affairs













BHC Stock - Frequently Asked Questions

Should I buy or sell Bausch Health Companies stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BHC shares.
View BHC analyst ratings
or view top-rated stocks.

What is Bausch Health Companies' stock price forecast for 2023?

1 equities research analysts have issued twelve-month price targets for Bausch Health Companies' stock. Their BHC share price forecasts range from C$26.00 to C$32.00. On average, they predict the company's share price to reach C$29.00 in the next twelve months. This suggests a possible upside of 175.7% from the stock's current price.
View analysts price targets for BHC
or view top-rated stocks among Wall Street analysts.

How have BHC shares performed in 2023?

Bausch Health Companies' stock was trading at C$8.50 at the beginning of the year. Since then, BHC stock has increased by 23.8% and is now trading at C$10.52.
View the best growth stocks for 2023 here
.

When is Bausch Health Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our BHC earnings forecast
.

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Enbridge (ENB), Aurora Cannabis (ACB), Manulife Financial (MFC), BlackBerry (BB), Bank of Nova Scotia (BNS), Toronto-Dominion Bank (TD), Nutrien (NTR), Suncor Energy (SU) and ARC Resources (ARX).

What is Bausch Health Companies' stock symbol?

Bausch Health Companies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BHC."

How do I buy shares of Bausch Health Companies?

Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Bausch Health Companies' stock price today?

One share of BHC stock can currently be purchased for approximately C$10.52.

How much money does Bausch Health Companies make?

Bausch Health Companies (TSE:BHC) has a market capitalization of C$3.81 billion and generates C$8.13 billion in revenue each year.

How many employees does Bausch Health Companies have?

The company employs 19,600 workers across the globe.

How can I contact Bausch Health Companies?

Bausch Health Companies' mailing address is 2150 Saint-Elzear Blvd W, Laval, Quebec H7L 4A8. The official website for the company is www.valeant.com. The company can be reached via phone at 514-744-6792.

This page (TSE:BHC) was last updated on 2/3/2023 by MarketBeat.com Staff